Market capitalization | SEK3.84b |
Enterprise Value | SEK3.71b |
P/E (TTM) P/E ratio | 27.25 |
EV/FCF (TTM) EV/FCF | 19.91 |
EV/Sales (TTM) EV/Sales | 5.13 |
P/S ratio (TTM) P/S ratio | 5.30 |
P/B ratio (TTM) P/B ratio | 4.70 |
Dividend yield | 1.55% |
Last dividend (FY24) | SEK2.50 |
As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.
3 Analysts have issued a CellaVision forecast:
3 Analysts have issued a CellaVision forecast:
Dec '24 |
+/-
%
|
||
Revenue | 723 723 |
7%
7%
|
|
Gross Profit | 487 487 |
5%
5%
|
|
EBITDA | 217 217 |
7%
7%
|
EBIT (Operating Income) EBIT | 178 178 |
6%
6%
|
Net Profit | 141 141 |
8%
8%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.
Head office | Sweden |
CEO | Simon Ostergaard |
Founded | 1994 |
Website | www.cellavision.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.